首页> 外国专利> HETEROARYLSUBSTITUTED DERIVATIVES OF 1,3-DIOXOLAN-4-YLMETHOXYPHENYL-1-PIPERAZINYLPHENYL-2,4-DIHYDRO- 2-ALKYL-3H-1,2,4-TRIAZOL-3-ONE, METHOD AND INTERMEDIATES FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS

HETEROARYLSUBSTITUTED DERIVATIVES OF 1,3-DIOXOLAN-4-YLMETHOXYPHENYL-1-PIPERAZINYLPHENYL-2,4-DIHYDRO- 2-ALKYL-3H-1,2,4-TRIAZOL-3-ONE, METHOD AND INTERMEDIATES FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS

机译:1,3-二氧戊环-4-基甲氧基苯基-1-哌嗪基亚苯基-2,4-二羟基-2-烷基-3H-1,2,4-三唑-3-基的杂芳基取代衍生物,其制备方法和药物制备

摘要

Heteroaryl-substituted 1,3-dioxolan-4-ylmethoxyphenyl-1-piperazinylphenyl-2,4-dihydro-2-alkyl-3H-1,2,4-triazol-3-one derivatives of formula (I) wherein A and B together represent a bivalent radical of formula -N = CH- (a), -CH = N- (b), -CH 2 -CH 2 - (c), -CH = CH- (d), -C (= O) -CH 2 (e) ) or -CH 2 -C (= O) - (f), wherein in the bivalent radical of formula (a) or (b) the hydrogen atom is optionally replaced by an alkyl group having 1 to 6 carbon atoms and in the bivalent radical of formula (c), (d) , (e) or (f) is optionally one or two hydrogen atoms replaced with C 1 -C 6 alkyl; R 1 is H, alkyl of 1 to 6 C or halogen; R 2 is H or halogen; R 3 is H, alkyl of 1 to 8 C, cycloalkyl of 3 to 6 C, or alkyl of 1 to 8 C substituted with hydroxyl, oxo, cycloalkyl of 3 to 6 C or aryl; Het is a heterocyclic radical as defined in the claims; and aryl is phenyl; optionally substituted with 1-6C alkyl or halogen; their N-oxides, stereochemically isomeric forms, and pharmaceutically acceptable acid addition salts thereof; intermediates of formula (III) wherein R 1, R 2 and Het are as defined above and W is a leaving group such as halogen or sulfonyloxy and their acid addition salts or stereochemically isomeric forms; a process for the preparation of compounds of formula (I) and pharmaceutical compositions thereof. The compounds of formula (I) are useful in the treatment of hyperlipidemia
机译:式(I)的杂芳基取代的1,3-二氧戊环-4-基甲氧基苯基-1-哌嗪基苯基-2,4-二氢-2-烷基-3H-1,2,4-三唑-3-酮衍生物一起表示式-N = CH-(a),-CH = N-(b),-CH 2 -CH 2-(c),-CH = CH-(d),-C(= O )-CH 2(e))或-CH 2 -C(= O)-(f),其中在式(a)或(b)的二价基团中,氢原子任选地被具有1至1的烷基取代。式(c),(d),(e)或(f)的二价基团中的6个碳原子任选被一个或两个被C 1 -C 6烷基取代的氢原子; R 1为H,1至6个碳的烷基或卤素; R 2为H或卤素; R 3为H,1至8个碳的烷基,3至6个碳的环烷基或被羟基,氧代,3至6个碳的环烷基或芳基取代的1至8个碳的烷基; Het是如权利要求中所定义的杂环基;芳基为苯基;任选地被1-6C烷基或卤素取代;它们的N-氧化物,立体化学异构形式及其药学上可接受的酸加成盐;式(III)的中间体,其中R 1,R 2和Het如上所定义,W是离去基团,例如卤素或磺酰氧基及其酸加成盐或立体化学异构形式;制备式(I)化合物及其药物组合物的方法。式(I)化合物可用于治疗高脂血症

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号